Post-prandial administration of the insulin analogue insulin aspart in patients with type 1 diabetes mellitus

Diabetic Medicine

Volumn 17, Issue 5, 2000, Pages 371-375

  Brunner, G A ^a   Hirschberger, S ^b   Sendlhofer, G ^a   Wutte, A ^a   Ellmerer, M ^a   Balent, B ^a   Schaupp, L ^a   Krejs, G J ^a   Pieber, T R ^a  

^a UNIVERSITY OF GRAZ   (Austria)

^b Novo Nordisk Pharma GmbH   (Germany)

Author keywords

Injection meal interval; Insulin analogue; Insulin aspart; Insulin therapy; Soluble human insulin

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HUMAN INSULIN; INSULIN ASPART; INSULIN DERIVATIVE; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIABETES CONTROL; DOUBLE BLIND PROCEDURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN TREATMENT; MALE; METABOLIC REGULATION; POSTPRANDIAL STATE; RANDOMIZED CONTROLLED TRIAL; TEST MEAL;

ADULT; BLOOD GLUCOSE; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; DOUBLE-BLIND METHOD; FEMALE; FOOD; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED;

EID: 0034089564     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2000.00289.x     Document Type: Article

References (21)

1. 1 Diabetes Control and Complications Research Group. The effect of íntensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
2. 2 Pieber TR, Brunner GA, Schnedl WJ, Schattenberg S, Kaufmann P, Krejs GJ. Evaluation of a structured outpatient education programme for intensive insulin therapy. Diabetes Care 1995; 18: 625-30.
3. 3 Brange J, Volund A. Insulin analogues with improved pharmacokinetic profiles. Advanced Drug Delivery Rev 1999; 35: 307-335.
4. 4 Brange J, Ribel U, Hansen JF, Dodson G, Hansen MT, Havelund S et al. Monomeric insulins obtained by protein engineering and their medical implications. Nature 1998; 333: 679-682.
5. 5 Howey DC, Bowsher RR, Brunelle RL, Woodworth JR. [Lys (B28), Pro (B29)]-human insulin: a rapidly absorbed analogue of human insulin. Diabetes 1994; 43: 396-402.
6. 6 Home PD, Lindholm A, Hylleberg B, Round P (Insulin Aspart study group). Improved glycemic control with insulin aspart - a multicenter randomized double-blind crossover trial in type 1 diabetic patients. Diabetes Care 1998; 21: 1904-09.
7. Lindholm A, McEwen J, Riis AP. Improved postprandial glycemic control with insulin aspart - a randomized double-blind crossover trial in type 1 diabetics. Diabetes Care 1999; 22: 801-805.
8. Heinemann L, Starke AAR, Hohmann A, Berger M. Timing between the subcutaneous administration of insulin and consumption of a carbohydrate rich meal. Horm Metab Res 1992; 26: 137-139.
9. Schernthaner G, Wein W, Sandholzer K, Equiluz-Bruck S, Bates PC, Birkett MA. Postprandial insulin lispro - a new therapeutic option for type 1 diabetic patients. Diabetes Care 1998; 21: 570-573.
10. Chanteleau E, Schiffers T, Schutze J, Hansen B. Effect of patient-selected intensive insulin therapy on quality of life. Pat Educ Couns 1997; 30: 167-173.
11. Torlone K, Pampanelli S, Lalli C, Del Sindaco P, Di Vincenzo A, Rambotti AM et al. Effects of the short-acting insulin analog [Lys (B28), Pro (B29)] on postprandial blood glucose control in IDDM. Diabetes Care 1996; 19: 945-952.
12. Heinemann L, Heise T, Klepper A, Ampudia J, Bender R, Starke AA. Time-action profiles of the intermediate-acting insulin analogue des(64,65)-human proinsulin. Diabete et Metabolisme 1995; 21: 415-419.
13. Dimitriades GD, Jerich JE. Importance of timing of preprandial subcutaneous insulin administration in the management of diabetes mellitus. Diabetes Care 1983; 6: 374-377.
14. Patrick AW, Collier A, Matthews DM, Macintyre CC, Clarke BF. The importance of the time interval between injection and breakfast in determining postprandial glycaemic control - a comparison between human and porcine insulin. Diabet Med 1988; 5: 32-35.
15. American Diabetes Association. Insulin administration. Diabetes Care 1999; 22: 83-86.
16. Barnett AH, Owens DR. Insulin analogues. Lancet 1997; 349: 47-.
17. Lean ME, Ng LL, Tennison BR. Interval between insulin injection and eating in relation to blood glucose control in adult diabetics. Br Med J Clin Res Ed 1985; 290: 105-108.
18. Berne C. Hypoglycemia and gastric emptying. Diabet Med 1996; 13: S28-30.
19. Kong MF, Macdonald IA, Tattersall RB. Gastric emptying in diabetes. Diabet Med 1996; 13: 112-119.
20. Schvarcz E, Palmer M, Aman J, Horowitz M, Stridsberg M, Berne C. Physiological hyperglycemia slows gastric emptying in normal subjects and patients with insulin-dependent diabetes mellitus. Gastroenterology 1997; 113: 60-66.
21. Berger M, Heinemann L. Are presently available insulin analogues clinically beneficial? Diabetologia 1997; 40: S91-S96.